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Abstract
The gut microbiota plays important roles in proper gut function and can contribute to or help prevent disease. Whole grains, including
oats, constitute important sources of nutrients for the gut microbiota and contribute to a healthy gut microbiome. In particular, whole
grains provide NSP and resistant starch, unsaturated TAG and complex lipids, and phenolics. The composition of these constituents is
unique in oats compared with other whole grains. Therefore, oats may contribute distinctive effects on gut health relative to other
grains. Studies designed to determine these effects may uncover new human-health benefits of oat consumption.
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The role that human colonic bacteria, or the gut microbiota,
plays in health and disease is an area of research with intense
current interest that is fuelled by provocative reports
suggesting that the gut microbiota plays a role in many
diseases that plague the modern society, including obesity,
diabetes and colorectal cancer(1). Diet plays an important,
albeit incompletely understood, role in maintaining healthy
gut–microbiota interactions(2). While a wealth of research
has focused on prebiotics and isolated dietary fibres and
their contribution to gut health(3), little research has been con-
ducted on how dietary fibres and other constituents from
whole-food matrices affect the gut microbiota.
Whole grains, for instance, are rich sources of dietaryfibres and
other bioactive compounds(4,5) that may modulate the gut micro-
biota and thereby impact on consumer health(6,7). In particular,
oats may contribute specialised influences on the gut microbiota
in comparison with other grains. Although most cereals contain
very little soluble dietary fibre, oats contain high levels of soluble
fibre in the form of mixed linkage (1! 3),(1! 4)-b-D-glucan
(hereafter, b-glucan)(8). Oats also contain the highest lipid
content among the major grains together with potential
bioactives(9,10). This article discusses the effects of whole grains
on gut health and then highlights some of the unique aspects
of oats that may contribute to enhanced gut health.
Influence of whole grains on the gut microbiota
Although the principal non-digestible components in whole
grains are cross-linked arabinoxylan and cellulose (see online
supplementary Table S1) – substrates that are generally
considered poor for gut microbial fermentation – whole grains
have the potential to play an important role in maintaining
a healthy gut microbiota. Two human trials have suggested
a bifidogenic effect from the consumption of whole-grain
cereals(6,7). Some strains of Bifidobacterium have been reported
in the literature as markers of a healthy gut microbiota(3).
Other studies have shown increases in butyrate-producing
bacteria, including Roseburia, Eubacterium rectale and the
Clostridium leptum group (which includes Faecalibacterium
prausnitzii)(11,12). Butyrate is an important metabolite of gut
microbial fermentation of carbohydrates for its contribution to
host colonic epithelial cell energy, anti-inflammatory properties
and anti-cancer effects(13). Whole grains have been shown to
decrease protein fermentation by the gut microbiota(14). Protein
fermentation is associated with undesirable fermentation metab-
olites and detrimental effects on the host(15). Whole grains may
also increase the diversity of the microbiota(12), a potential benefit
considering that reduced diversity is associated with obesity and
disease(16,17). Notably, consumption of many purified dietary
fibres has not been shown to increase diversity(18,19).
The beneficial effects of whole grains on health are likely to
be a combined result of many components within the grain
rather than one specific component(5). Three components of
whole grains that are likely to impact the gut microbiota
with trophic effects on the host are discussed later.
Dietary fibre
The insoluble, NSP in cereals have long been recognised for
their faecal bulking properties and reduction in gastrointestinal
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transit time(20). These effects may be particularly important for
older adults, who typically consume less dietary fibre and
have reduced gastric motility(21). However, because of their
poor utilisation by colonic bacteria, the impact of NSP on the
gut microbiota is often overlooked. The poorly fermentable,
dietary fibres in whole grains contribute to reduced distal
colonic pH and higher faecal butyrate concentrations(22,23).
This is likely because the poor fermentation of the NSP
allows it to persist into the distal colon and provide some carbo-
hydrate substrate for gut bacterial metabolism in this region,
a characteristic not attributable to most soluble and highly
fermentable dietary fibres. Such conditions are consistent with
reduced inflammation and carcinoma development(13,24).
In addition to the principal NSP in whole grains, they also
contain water-extractable arabinoxylan and mixed-linkage
b-glucan (see online supplementary Table S1). The extent of
fermentation and the types of bacteria that are favoured with
these polymers depend on solubility, monosaccharide compo-
sition, presence of non-carbohydrate moieties, molecular
weight and glycosidic linkages(25,26). Viscosity was reported to
affect the types of bacterial groups that are enriched with
b-glucan(27), although because the viscous property of
b-glucan is rapidly lost upon contact with gut bacteria(28) it is
likely that these differences were due to molecular weight
rather than viscosity. Fermentation of isolated water-extractable
arabinoxylan and b-glucan by human intestinal bacteria in vitro
is generally associated with an enrichment in propionate
production compared with other dietary fibres(25,29–34).
Important propionate producers in the gut microbiota are mem-
bers of clostridial cluster IX and Bacteroides (35). Neither one
of these polysaccharides is particularly bifidogenic, although
bifidogenicity increases when partially hydrolysed(25,36).
Whole grains also contain widely varying quantities of resistant
starch (RS), depending on the types of grain used and product
and processing conditions(37). RS has received considerable
attention in recent years for its influence on the gut microbiota
and subsequent impacts on the host(18). Even though the exact
content type of RS in most whole-grain foods is fairly modest
(typically 1–3%)(37), this may still have a positive impact on
health. For instance, in subjects who consumed whole-wheat
or wheat-bran cereals, a bifidogenic effect was only observed
in the whole-wheat cereal(6). The difference between the two
cereals was mainly the starch content. This suggests that the pre-
biotic effect of the whole-grain cereals could have been at least
partially a result of RS fermentation, as RS has shown prebiotic
properties(18). Furthermore, RS is also particularly butyrogenic,
and in an in vitro trial, Costabile et al.(6) found greater butyrate
production when the whole-grain wheat cereal was fermented
with faecal bacteria compared with the wheat-bran cereal.
Finally, whole grains contain about 0·1–1 % a-galactosyl
derivatives of sucrose (mainly raffinose and stachyose) and
0·3–4 % b-fructosyl derivatives of sucrose (referred to as fruc-
tan; see online supplementary Table S1). These carbohydrates
are generally located in the outer portions of the grain, with
raffinose and stachyose concentrated in the germ(5). Although
their content in grain products is fairly low compared with
some other plants, the prevalence of grain-based foods in
the diet makes them an important dietary source of these
carbohydrates(38). Raffinose and stachyose are rapidly fermen-
table and bifidogenic(3). These carbohydrates also possess
several health benefits(39). When consumed as isolated ingre-
dients, they can cause boating, flatulence and, at very high
intakes, diarrhoea(39); however, these high intakes are not
likely to be achieved through whole-grain consumption. The
fructans in whole grains contain an average degree of poly-
merisation of four to six with few oligomers containing
more than nine degrees of polymerisation(40). Furthermore,
fructans in whole grains contain branched structures with
both (2! 1) and (2! 6) b-fructosyl linkages(41). No studies
have isolated fructans from any whole grain and determined
its fermentation properties; however, short-chain fructan
oligomers are generally rapidly fermented by gut bacteria
and highly bifidogenic(3). Several reviews have demonstrated
the positive impact that fructans impart on human health(42,43).
Lipids
Evidence in mice has suggested that diets high in fat in the
form of bulk lipids (predominantly TAG) have a detrimental
effect on the gut microbiota and host metabolic parameters(44).
In particular, diets high in saturated fats have been shown to
decrease proportions of beneficial bacteria(45) and decrease
microbial diversity(46). de Wit et al.(46) suggested that saturated
fats were especially detrimental to the gut microbiota because
they persisted into the distal small intestine where they
exhibited an antimicrobial effect (and consequently reduced
diversity). Whole grains are comparatively low in fat, and
the fat that they do contain is highly unsaturated.
Whole-grain lipids themselves may also more directly affect
the gut microbiota with subsequent influences on health.
For instance, hamsters fed diets supplemented with up to
5 % wholegrain sorghum lipids showed significantly increased
Bifidobacteria and decreased Coriobacteriaceae in the
faeces(47). Bifidobacteria concentration was positively
correlated with plasma HDL-concentration, while Coriobacter-
iaceae were positively correlated with non-HDL-cholesterol
and cholesterol absorption. In another study(48), rice bran oil
incorporated into the diets of mice increased bile acids in
the faeces with accompanying positive correlations with the
family Lactobacillales (which contains lactic acid bacteria).
Martı´nez et al.(49) theorised that this was due to the sterol
esters in the lipid extract (about 10 %). When hamsters were
fed purified steryl esters, cholesterol absorption decreased,
which led to an increase in the cholesterol pool in the gut
and a decrease in Coriobacteriaceae and Erysipelotrichaceae.
These two families have shown positive correlations with
deleterious host lipid parameters(47,50). Whole grains are rich
sources of plant sterol esters in comparison with other
foods(51). In addition, other lipid components of grains, for
example the policosanols, may also affect the gut microbiota,
although this remains to be determined.
Phenolics
The majority of the antioxidants in whole grains are bound to
dietary fibre components, precluding their absorption in the
Whole grains, oats and the gut microbiota S45
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upper gastrointestinal tract(52). However, microbial-derived
esterases in the lower gastrointestinal tract can release a portion
of these compounds from their dietary fibre conjugates, where-
upon they are rapidly metabolised. Ferulic acid, the major
phenolic acid in whole grains, for instance, is first hydrogenated
at the double bond on the propen-2-oic acid side chain
followed by demethylation of the ring diethyl ether.
Subsequently, this metabolite, 3,4-dihydroxyphenylpropionic
acid, is dehydroxylated to 3-hydroxyphenylpropionic acid and
phenylpropionic acid(53). Dimers and oligomers of ferulic acid
are also present in whole grains and metabolised either by
direct modification of the functional groups or by deconjuga-
tion and metabolism as monomers(54). These metabolites may
impart beneficial biological activity(55), although there are still
many questions regarding the effective dose, bioavailability
and pharmacokinetics of these compounds in humans.
While microbial esterases are effective at removing a
variable portion of bound phenolics, which depends on
many factors(53), many phenolics are still not biologically avail-
able(56). However, the physical presence of high concentrations
of bound phenolic antioxidants in the gastrointestinal tract may
itself impart several benefits. While the body contains natural
defence mechanisms against free radical oxidation, the lumen
of the gastrointestinal tract is not protected to the same
extent. Furthermore, under some circumstances, such as
during inflammation, neutrophils produce free radicals
(e.g. HNO3) that can lead to mucosal oxidative stress,
peroxidation of membrane lipids and tissue damage(57,58).
The presence of bound antioxidants in the lumen, such as
those in whole grains, may protect the intestinal epithelium
from free radical damage(56). This is supported by studies show-
ing that the physical presence of ferulic acid in the lumen of the
large intestine, administered via enema, leads to reduced
inflammation in inflammatory bowel disease patients(59).
What about oats?
As with other whole grains, in vivo trials on the effects of oats
on markers of gut health are sparse (see online supplementary
Table S2). There are comparatively more in vitro studies; how-
ever, the data are far from comprehensive and in many cases
conflicting (see online supplementary Table S3). Nevertheless,
as mentioned, oats contain a unique chemical composition
compared with other grains. The most prevalent differences
are in the dietary-fibre composition, the lipid content and the
types of phenolics. Because these three fundamental com-
ponents are likely to have strong effects on the gut microbiota,
as discussed, oats are likely to impact the gut microbiota in
unique ways compared with other cereal grains. Studies
aimed at elucidating these effects may help researchers further
establish the mechanisms behind the health benefits of oats,
and help breeders and food companies create oats and oat pro-
ducts that maximise the health benefits derived from this grain.
Dietary fibre
The high content of b-glucan is the most unique dietary fibre
component in oats. While the viscous property of b-glucan
is rapidly diminished once b-glucan is exposed to microbial
metabolism in the large bowel(28), fermentation of b-glucan
by some gut microbes may play a role in the effects of
whole-grain oats and barley on heart diseases. For instance,
as mentioned, fermentation of isolated b-glucan generally
enhances the production propionate by the gut micro-
biota(25,31,33), and studies suggest that propionate may help
reduce serum cholesterol(60). b-Glucan may also contribute
to reduced colonic pH compared with other cereals contain-
ing less soluble (and fermentable) dietary fibres(61).
RS content of oats may be an important contributor to its
effects on gut health. Connolly et al.(62) studied the differences
in in vitro fermentation properties between thin and thick oat
flakes (rolled oats). The thick oat flakes resulted in a significant
increase in Bifidobacterium during fermentation compared with
the baseline; this was not observed in the thin oat flakes.
Moreover, the thick oat flakes resulted in 2·5 times more
butyrate than the thin oat flakes. The authors suggested that
the bifidogenic effect and the enhanced butyrate production
in the presence of thick oat flakes were results of higher RS
in these samples compared with the thin oat flakes. This was
supported by another study where oat flours were subjected
to in vitro digestion to remove digestible components before
faecal fermentation; however, the residue still contained about
15% starch(63). The subsequent fermentation resulted in an
acetate–propionate–butyrate ratio of about 42:24:35, which is
typical of starch-containing preparations(64). High b-glucan in
oat and barley cereals has been shown to reduce starch
digestion in the small intestine due to its viscosity(65). Thus, it
is possible that oats and barley products contain higher RS
than products from other grains because the starch digestion
rate may be sufficiently slow as to allow a greater portion
of starch to remain intact and reach the colon(66).
In spite of their similarities in dietary fibre composition,
oats and barley seem to induce different effects on the gut
microbiota. For example, pigs consuming an oat-based diet
showed significantly greater increases in bifidobacteria com-
pared with pigs consuming a barley-based diet(67). Another
study by the same group showed a greater bifidogenic effect
on an oat-based diet compared with a wheat-based diet that
was supplemented with b-glucan such that the two diets
had a similar b-glucan content(68). The different influences
that oats and barley have on the gut microbiota may be due
to differences in the structures and molecular weight of
b-glucan or other polysaccharides, as well as differences in
non-dietary fibre components.
Lipids
Although lipid components from whole grains affect the gut
microbiota, more research is needed to describe such effects
in detail. No studies have demonstrated the effects of isolated
oat lipids on the gut microbiota. In the studies cited earlier,
plant sterols may affect changes in the gut microbiota with posi-
tive impacts on health. Oats contain moderate concentrations of
sterols (329–520mg/kg): lower than wheat and rye (603–715
and 910–1100mg/kg, respectively), but higher than rice and
sorghum (216–401 and 200–350mg/kg, respectively)(51,69,70).
D. J. RoseS46
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Phenolics
While the majority of phenolics in oats are bound ferulic acid,
which is similar to other whole grains, oats also contain some
unique phenolics including avenacosylates, avenacins and
avenanthramides. Avenacosylates are esters of ferulic or caffeic
acid with a long-chain wax alcohol (policosanol) and are pre-
sent in oats at about 50–200 mg ferulic acid equivalents/kg(9).
The avenacins arepentacyclic triterpene alcohol glycosides con-
taining esters of aminophenolic or benzoic acid(9). Avenanthra-
mides are conjugates of a phenylpropanoid with anthranilic acid
or 5-hydroxy anthranilic acid and are present in oats in widely
varying concentrations similar to the avenocosylates(9). It is
likely that these compounds are metabolised by the gut micro-
biota, but this has not been reported in detail(71). Some data
suggest that they may function as anti-inflammatory molecules
and protect the gut mucosa by modulating NF-kB activation(72).
Conclusions
Whole-grain dietary fibres, despite being poorly fermented
in many cases, are the major contributors to distal colonic
fermentation(22,23), which results in a decrease in pH and
potentially reduces the risk of some gastrointestinal
diseases(73). Furthermore, RS may be a significant contributor
to the benefits of whole grains(66) and could be responsible
for the bifidogenic effect of whole-grain cereals previously
reported(6,7). Other constituents in whole grains that are
often ignored in relation to gut health, namely the lipids and
phenolic constituents, may also contribute to gut health(4,5).
Oats are a unique whole grain that may contribute
distinctive effects on the gut microbiota. These effects could
be due to the high b-glucan content, the high lipid content
or the unique antioxidant profile. b-Glucan fermentation
could contribute to the hypocholesterolaemic properties of
oats(25). Furthermore, b-glucan may slow the rate of starch
digestion and help increase the RS content of oats relative to
other grains that are low in b-glucan(65,66). Oat lipids and
antioxidants have not been studied in relation to gut health,
but research in other whole grains suggests that they influence
the types of bacteria that make up the microbiota and impact
on host health(47,55,72). The microbiota and gut health are at
the intersection of emerging research, particularly when
considering the demonstrated and possible health implications
of whole grains and dietary fibre that are identified in oats.
Supplementary material
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